| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.19 | 0.003 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |